Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: jmhollen who wrote (480)	10/17/2006 5:32:31 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 557

I dropped it from the handful of stocks I had in the 'picks of the quarter' contest--a buy signal if ever there was one. I'd like to have listened to the Ceregene call at BIO as well, too bad--there are a handful of ways this company can survive and pairing the expertise with AAV with a new, obviously high-profile, therapy might do the trick. Or the arthritis therapy may work... As I said, no position myself, but it wouldn't break my heart to see it double and my buddy get some of his money back. I was surfing and and article came up on Forbes-- it was old, from 2000 or '02. Did you know that Parker was one of the biotech all-stars in Forbes that year? I'd like to see them refresh that article. I like tgen, they've been slogging at it so long they deserve a break, and shareholders deserve a run up too.